-
CorMedix Prices $20M Public Offering of Common Stock
Post on 7/28/20
-
DriveWealth Partners with MotivHealth
Post on 7/28/20
-
Karuna Therapeutics and PsychoGenics Announce Drug Discovery Collaboration
Post on 7/28/20
-
PCI Pharma Services Announces Global Expansion of Clinical Trial Services
Post on 7/28/20
-
Pfizer, BioNTech Choose Coronavirus Vaccine Candidate to Advance to Phase 2/3 Trial
Post on 7/28/20
-
CorMedix Proposes Public Offering of Common Stock
Post on 7/27/20
-
Palatin Technologies Announces Mutual Termination of License Agreement with AMAG Pharmaceuticals for Vyleesi
Post on 7/27/20
-
Telemedicine Keeps Maris Grove Residents Safe during COVID-19
Post on 7/27/20
-
Venatorx Pharmaceuticals Awarded up to $44.2 Million to Advance Novel Inhibitors of Penicillin Binding Proteins
Post on 7/27/20
-
Emergent BioSolutions Signs Agreement with AstraZeneca to Expand Manufacturing for COVID-19 Vaccine Candidate
Post on 7/27/20
-
Could Pfizer Be a Millionaire-Maker Stock?
Post on 7/27/20
-
Is Johnson & Johnson an Underdog in the COVID-19 Vaccine Race?
Post on 7/27/20
-
Should Inovio Pharmaceuticals Be Your Next Coronavirus Buy?
Post on 7/27/20
-
Vynamic Announces Partnership with Innovations in Healthcare
Post on 7/24/20
-
Alfasigma USA Engages Indegene to Expand the Promotion of ZELNORM to Healthcare Professionals in the United States
Post on 7/23/20
-
Conduent Healthcare Payer Solutions Recognized as Leader and Star Performer in Everest Group PEAK Matrix Report
Post on 7/23/20
-
Is Now a Good Time to Buy Pfizer Stock?
Post on 7/23/20
-
Pfizer and BioNTech Ink Deal with U.S. Government for Big Coronavirus Vaccine Purchase
Post on 7/23/20
-
Zelira Therapeutics Enters Agreement with Cardiovascular Solutions of Central Mississippi
Post on 7/22/20
-
Hackensack Meridian Health Partners with Genomic Testing Cooperative
Post on 7/22/20
-
Vesigen Therapeutics Launches with $28.5M Series A
Post on 7/22/20
-
CytoSorbents Prices $50M Public Offering
Post on 7/22/20
-
NovoCure: A Disrupter In Oncology
Post on 7/22/20
-
What's Behind Novartis' Disappointing Q2 Results
Post on 7/22/20
-
Ortho Care Again Ranks No. 1 for Service in Diagnostics Industry
Post on 7/21/20
Philadelphia
